Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune Checkpoint Inhibitors (ICIs)”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Not applicableUnknownNCT04492969
What this trial is testing

Prospective Observation of Failure Patterns in NSCLC Treated With ICIs

Who this might be right for
NSCLC Stage IVNSCLC, Recurrent
Fudan University 320
Not applicableLooking for participantsNCT06669377
What this trial is testing

TACE Combined With ICIs Plus MTT After 125I Irradiation Stent Placement in HCC With Main PVTT.

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 444
Not applicableLooking for participantsNCT05754203
What this trial is testing

Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC

Who this might be right for
Lung CancerImmune Checkpoint InhibitorRadiotherapy
Xinqiao Hospital of Chongqing 40
Not applicableStudy completedNCT05688046
What this trial is testing

Efficacy and Safety Analysis of ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced NSCLC in Elderly Patients

Who this might be right for
NSCLC
Suzhou Municipal Hospital 79
Not applicableStudy completedNCT06522048
What this trial is testing

SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs

Who this might be right for
Immune Checkpoint Inhibitor-Induced DermatitisStevens-Johnson Syndrome, Drug-InducedToxic Epidermal Necrolysis Due to Drug
Chao Ji 300
Not applicableActive Not RecruitingNCT06518018
What this trial is testing

Efficacy and Safety of High-Dose Rate Brachytherapy with Immunotherapy and Chemotherapy As Second-Line Treatment for Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Stage NSCLCSecond-line TreatmentPatients Without Targetable Driver Mutations
The First People's Hospital of Neijiang 80
Testing effectiveness (Phase 2)Looking for participantsNCT06675201
What this trial is testing

Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Neoantigen-loaded Dendritic Cell VaccineImmune Checkpoint Inhibitors (ICIs)
Sichuan University 165
Testing effectiveness (Phase 2)Looking for participantsNCT07157969
What this trial is testing

ICIs and Anti-VEGF Antibody/TKIs With or Without Interventional Therapy for Advanced HCC

Who this might be right for
HCC - Hepatocellular Carcinoma
Peking Union Medical College Hospital 300
Very early researchLooking for participantsNCT06329908
What this trial is testing

DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs

Who this might be right for
Lung Cancer
Zhen-Yu Ding 20
Not applicableStudy completedNCT06119347
What this trial is testing

Acute Kidney Injury in Cancer Patients Receiving Anti-Vascular Endothelial Growth Factor Monoclonal Antibody vs Immune Checkpoint Inhibitors

Who this might be right for
AKI Incidence of Cancer Patients Receiving AntiVEGF or ICIs
First Affiliated Hospital of Wenzhou Medical University 1,581
Not applicableStudy completedNCT05942872
What this trial is testing

CICLOPS Immune Checkpoint Inhibitors Neurotoxicity: Long-term Outcomes, Predictors, and Survival.

Who this might be right for
Paraneoplastic Syndromes
Hospices Civils de Lyon 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05824481
What this trial is testing

Study of Cadonilimab (AK104) Plus Lenvatinib in Patients With Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Sun Yat-sen University 32
Not applicableLooking for participantsNCT05484908
What this trial is testing

Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC

Who this might be right for
Immune-Mediated HepatitisLiver FailureHepatocellular Carcinoma
Third Affiliated Hospital, Sun Yat-Sen University 60
Not applicableLooking for participantsNCT07141056
What this trial is testing

The Impact of Emotional Stress on Immunotherapy Outcomes in Liver Cancer Patients: A Multi-Cohort Study

Who this might be right for
HCC - Hepatocellular CarcinomaPsychological DistressImmune Checkpoint Inhibitors (ICIs)+2 more
Guilin Medical University, China 700
Not applicableUnknownNCT05725915
What this trial is testing

Prediction Model of ICIs Combined With Chemotherapy in Advanced NSCLC

Who this might be right for
Lung Cancer, Nonsmall Cell
Beijing Red Clove Public Welfare Development Center 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06951646
What this trial is testing

CtDNA-MRD Guided Escalation of Ivonescimab and Docetaxel in Advanced NSCLC With Long-Term Responses to First-line Immunotherapy (CR1STAL-Adaptive)

Who this might be right for
Non Small Cell Lung CancerImmune Checkpoint Inhibitors (ICIs)
Second Xiangya Hospital of Central South University 70
Testing effectiveness (Phase 2)Looking for participantsNCT06446154
What this trial is testing

Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaImmune Checkpoint InhibitorsAnti-angiogenic Therapy+1 more
Sun Yat-sen University 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06066216
What this trial is testing

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Adenocarcinoma
Fujian Cancer Hospital 45
Not applicableStudy completedNCT06435013
What this trial is testing

Lenvatinib vs Bevacizumab Plus ICIs and HAIC in Unresectable HCC

Who this might be right for
Hepatocellular CarcinomaLenvatinib
Sun Yat-sen University 208
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06563934
What this trial is testing

Gut Microbiota in Liver Cancer (Treated With TKIs In Combination With ICIs)

Who this might be right for
Liver Cancer
Xu Yong, MD 70
Load More Results